Hyliion (HYLN)
(Delayed Data from NYSE)
$1.63 USD
-0.05 (-2.98%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $1.63 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Hyliion Holdings Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 2 | 0 | 0 | 0 |
Cost Of Goods | 2 | 9 | 3 | 0 | 0 |
Gross Profit | -1 | -7 | -3 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 136 | 152 | 94 | 22 | 1 |
Income After Depreciation & Amortization | -137 | -159 | -96 | -22 | -1 |
Non-Operating Income | 14 | 6 | 0 | -12 | 4 |
Interest Expense | NA | 0 | 0 | 5 | 0 |
Pretax Income | -124 | -153 | -96 | -39 | 3 |
Income Taxes | NA | 0 | 0 | 0 | 1 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -124 | -153 | -96 | -39 | 2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -124 | -153 | -96 | -39 | 2 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -137 | -157 | -93 | -17 | -1 |
Depreciation & Amortization (Cash Flow) | 1 | 2 | 3 | 5 | 0 |
Income After Depreciation & Amortization | -137 | -159 | -96 | -22 | -1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 181.41 | 175.40 | 172.22 | 104.32 | NA |
Diluted EPS Before Non-Recurring Items | -0.63 | -0.87 | -0.56 | -0.31 | NA |
Diluted Net EPS (GAAP) | -0.68 | -0.87 | -0.56 | -0.38 | 0.08 |
Fiscal Year end for Hyliion Holdings Corp falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.10 | 0.27 |
Cost Of Goods | 0.00 | 0.00 | 0.04 | 0.68 | 0.31 |
Gross Profit | 0.00 | 0.00 | -0.04 | -0.58 | -0.04 |
SG&A, R&D, and Dept/Amort Expenses | 14.02 | 18.99 | 21.12 | 33.31 | 38.54 |
Income After SG&A, R&D, and Dept/Amort Expenses | -14.02 | -18.99 | -21.16 | -33.89 | -38.58 |
Non-Operating Income | 3.16 | 3.40 | 3.50 | 3.56 | 3.35 |
Interest Expense | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Pretax Income | -10.86 | -15.59 | -29.13 | -30.32 | -35.23 |
Income Taxes | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | NA | 0.00 | 0.00 |
Income From Cont. Operations | -10.86 | -15.59 | -29.13 | -30.32 | -35.23 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -10.86 | -15.59 | -29.13 | -30.32 | -35.23 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 173.83 | 178.48 | 182.89 | 181.64 | 180.97 |
Diluted EPS Before Non-Recurring Items | -0.06 | -0.07 | -0.11 | -0.17 | -0.19 |
Diluted Net EPS (GAAP) | -0.06 | -0.09 | -0.16 | -0.17 | -0.19 |